CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT00224601
Collaborator
(none)
80
1
30
2.7

Study Details

Study Description

Brief Summary

The aim of the study is to test the hypothesis that a chromoscopy colonoscopy is able to increase by 50 % the number of pre-cancer lesions or early cancer detected in patients with HNPCC syndrome, compared to a routine colonoscopy without chromoscopy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Colonoscopy with chromoscopy
Phase 2

Detailed Description

Patient with HNPCC syndrome confirmed by a mutation (MLH1, MSH2, MHS1) are involved in the study. Patient have 2 colonoscopy back to back. The second coloscopy is associated to chromoscopy with carmin indigo. Endoscopist are randomised for the colonoscopy with chromoscopy and are un-awarded of the result of the first colonoscopy. Histopathology of the polyp are noted. The follow up were 1 month.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome: Assessment of Coloscopy With Chromoscopy Benefit
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Jan 1, 2008
Actual Study Completion Date :
Jan 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Number of pre-cancer lesions or early cancer detected. [during the procedure]

Secondary Outcome Measures

  1. Anatomopathologic criteria (size of lesions, …). [during the procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with MLH1, MSH2 or MSH6 mutation.

  • Patients concerned by early detection colonoscopy.

Exclusion Criteria:
  • Coloscopy of tracking since less 1an

  • occlusive Syndrome contra-indicating the preparation for a total coloscopies

  • Colectomies

  • medical Conditions or serious illnesses contra-indicating a coloscopy of screening

  • pregnant Woman or nursing

  • Anomaly of coagulation contra-indicating the realization of biopsies and/or the exeresis of the lesion colorectal

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Europeen Georges Pompidou Paris Ile de France France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Christophe CELLIER, Pr,MD,PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00224601
Other Study ID Numbers:
  • P040423
First Posted:
Sep 23, 2005
Last Update Posted:
Feb 18, 2011
Last Verified:
Jul 1, 2007

Study Results

No Results Posted as of Feb 18, 2011